Medicare AdvantageCoverageMedium impact
Genetic Testing for Hereditary Colorectal and Uterine Cancer - Medicare Advantage (Revised)
Humana·Oncology, Gastroenterology, OB-GYN +3 more·Medicare Advantage
Effective date
Apr 1, 2026
We identified it
Jun 24, 2026
Summary
Humana Medicare Advantage has revised its genetic testing policy for hereditary colorectal and uterine cancer, updating coverage determinations and coding requirements. The policy consolidates guidance for Lynch syndrome, polyposis syndromes, and related genetic testing with an effective date of April 1, 2026.
Action Required
Before April 1, 2026: Billing team must review and update genetic testing protocols for hereditary colorectal and uterine cancer per Humana Medicare Advantage policy HUM-1106-009. Verify MAC-specific LCD requirements based on practice location as coverage varies by jurisdiction. Update prior authorization workflows and documentation requirements for genetic testing panels including Lynch syndrome and polyposis syndrome testing.